Chiasma Inc (NASDAQ:CHMA)

4.20
Delayed Data
As of Jun 11
 +0.02 / +0.48%
Today’s Change
2.77
Today|||52-Week Range
7.75
-3.45%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$243.2M

Company Description

Chiasma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of oral forms of therapies that are available by injection. Its products include octreotide capsules. The company was founded by Shmuel A. Ben-Sasson and Guy Yachin in 2001 and is headquartered in Needham, MA.

Contact Information

Chiasma, Inc.
140 Kendrick Street
Needham Massachusetts 02494
P:(617) 928-5300
Investor Relations:

Employees

Shareholders

Other institutional45.42%
Mutual fund holders22.31%
Individual stakeholders20.80%

Top Executives

Raj KannanPresident, Chief Executive Officer & Director
John DoyleChief Financial Officer, Treasurer & Senior VP
Asi HavivVice President-Clinical Development
Gary PatouHead-Clinical
Ethel M. KoczonVice President-Clinical Operations